| ALMIRALL S.A. EO -,12 | 12.580 / +0.88% |
| Date/Time | 04/16 / 08:08 |
| Chg. / Chg.(%) | 0.110 / +0.88% |
| Bid | - |
| Ask | - |
| Open | 12.580 |
| Previous Close | 12.470 |
| High | 12.580 |
| Low | 12.580 |
| Volume [EUR] | 0.000 |
| Volume [Units] | 0 |
| Price fixings | 1 |
| ISIN | ES0157097017 |
| Security | E2Z |
| Exchange | Berlin |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 12.460 |  |
|
| Madrid | 12.5500 | |
236,965 |
| Cboe Europe .. | 12.55 | |
49,249 |
| London Inter.. | 12.53 | |
44,474 |
| Turquoise | 12.54 | |
10,341 |
| Cboe Europe .. | 12.50 | |
810 |
| Cboe Europe .. | 12.50 | |
803 |
| Frankfurt | 12.5700 | |
0 |
| Berlin | 12.580 | |
0 |
| Stuttgart | 12.470 |  |
0 |
| TradeGate | 12.41 | 640 | |
| Nasdaq Other.. | 15.0000 | 1,000 |
News
- Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
04/01/2021 / 22:01 - GlobeNewswire - Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications
03/24/2021 / 12:00 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
03/01/2021 / 22:01 - GlobeNewswire - Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update
03/01/2021 / 13:05 - GlobeNewswire - Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million
02/24/2021 / 22:01 - GlobeNewswire
Real-time